Gland Pharma has announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Latanoprost Ophthalmic Solution, 0.005 per cent (2.5 mL fill)
Read More
Trazodone tablets are prescribed for the treatment of major depressive disorder in adults
Read More
The facility has been granted a Voluntary Action Indicated (VAI) status following an inspection that took place from May 7 to May 17, 2024
Read More
